Ticker: CGEN

09:34am, Wednesday, Dec 17, 2025

Compugen's Shares Jump as AstraZeneca Pays $65M Upfront for Rilvegostomig Royalties

Compugen Ltd. (NASDAQ:CGEN) gains 12.8% premarket after a $65M upfront royalty deal with AstraZeneca (NASDAQ:AZN) tied to cancer drug rilvegostomig's future sales and milestones.